Cargando…

Risk Factors for Mortality in Anti-NMDAR, Anti-LGI1, and Anti-GABABR Encephalitis

OBJECTIVE: We aimed to investigate the mortality rate and identify the predictors of death in patients with anti-NMDAR, anti-LGI1, and anti-GABABR encephalitis. METHODS: Patients with anti-NMDAR, anti-LGI1, and anti-GABABR encephalitis were recruited from the Neurology Department of the First Hospit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Rui, Chen, Qingling, Zhang, Xinyue, Zhang, Hanyu, Lin, Weihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934853/ https://www.ncbi.nlm.nih.gov/pubmed/35320933 http://dx.doi.org/10.3389/fimmu.2022.845365

Ejemplares similares

Relapses of Anti-NMDAR, Anti-GABABR and Anti-LGI1 Encephalitis: A Retrospective Cohort Study
por: Zhong, Rui, et al.
Publicado: (2022)

Comprehensive B-Cell Immune Repertoire Analysis of Anti-NMDAR Encephalitis and Anti-LGI1 Encephalitis
por: Feng, Jingjing, et al.
Publicado: (2021)

Anti‐LGI1, anti‐GABABR, and Anti‐CASPR2 encephalitides in Asia: A systematic review
por: Ghimire, Prinska, et al.
Publicado: (2020)

Seizures and risk of epilepsy in anti‐NMDAR, anti‐LGI1, and anti‐GABA(B)R encephalitis
por: Shen, Chun‐Hong, et al.
Publicado: (2020)

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA(B)R encephalitis
por: de Bruijn, Marienke A.A.M., et al.
Publicado: (2019)

Positive LGI1 Antibodies in CSF and Relapse Relate to Worse Outcome in Anti-LGI1 Encephalitis
por: Cui, Li-li, et al.
Publicado: (2021)

A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies
por: Ji, Tuo, et al.
Publicado: (2020)

SCLC and anti‐GABABR encephalitis: A retrospective analysis of 60 cases in China
por: Jiang, Chunguo, et al.
Publicado: (2022)

Presence of Anti-Thyroid Antibodies Correlate to Worse Outcome of Anti-NMDAR Encephalitis
por: Chen, Zhongyun, et al.
Publicado: (2021)

Characteristics and Outcomes of Paroxysmal Sympathetic Hyperactivity in Anti-NMDAR Encephalitis
por: Chen, Zhongyun, et al.
Publicado: (2022)

Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination
por: Zlotnik, Yair, et al.
Publicado: (2022)

Case report: Anti-IgLON5 disease and anti-LGI1 encephalitis following COVID-19
por: Li, Yanfei, et al.
Publicado: (2023)

The diagnosis of anti-LGI1 encephalitis varies with the type of immunodetection assay and sample examined
por: Muñoz-Sánchez, Guillermo, et al.
Publicado: (2022)

CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study
por: Nissen, Mette Scheller, et al.
Publicado: (2021)

Psychiatric Manifestation of Anti-LGI1 Encephalitis
por: Endres, Dominique, et al.
Publicado: (2020)

Case Report: Paroxysmal hyperhidrosis as an initial symptom in a patient with anti-LGI1 encephalitis
por: Qiao, Tingting, et al.
Publicado: (2022)

Overlapping anti-NMDAR encephalitis and multiple sclerosis: A case report and literature review
por: Liu, Pan, et al.
Publicado: (2023)

Novel qEEG Biomarker to Distinguish Anti-NMDAR Encephalitis From Other Types of Autoimmune Encephalitis
por: Mizoguchi, Tomotaka, et al.
Publicado: (2022)

Molecular Pathogenesis of Anti-NMDAR Encephalitis
por: Ding, Hao, et al.
Publicado: (2015)

The Chinese experience with anti-NMDAR encephalitis
por: Desestret, Virginie
Publicado: (2020)

Psychiatric manifestations of anti-NMDAR encephalitis
por: Martins, D., et al.
Publicado: (2021)

Anti-NMDAR encephalitis for psychiatrists: the essentials
por: Beattie, Matthew, et al.
Publicado: (2022)

Cell-Free Mitochondrial DNA in the CSF: A Potential Prognostic Biomarker of Anti-NMDAR Encephalitis
por: Peng, Yu, et al.
Publicado: (2019)

Prodromal headache in anti‐NMDAR encephalitis: An epiphenomenon of NMDAR autoimmunity
por: Tominaga, Naomi, et al.
Publicado: (2018)

High Dose Steroids as First-Line Treatment Increased the Risk of In-Hospital Infections in Patients With Anti-NMDAR Encephalitis
por: Wang, Jierui, et al.
Publicado: (2021)

Anti-LGI1 encephalitis with initiating symptom of seizures in children
por: Wang, Yang, et al.
Publicado: (2023)

Acute Symptomatic Seizures and Risk of Epilepsy in Autoimmune Encephalitis: A Retrospective Cohort Study
por: Zhong, Rui, et al.
Publicado: (2022)

Thyroid Function and Anti-thyroid Antibodies in Pediatric Anti-NMDAR Encephalitis
por: Chen, Lianfeng, et al.
Publicado: (2021)

Anti-LGI1 Limbic Encephalitis Presented with Atypical Manifestations
por: Lee, Jung-Ju, et al.
Publicado: (2013)

Neuroleptic intolerance in patients with anti-NMDAR encephalitis
por: Lejuste, Florian, et al.
Publicado: (2016)

353. HSV-Induced Anti-NMDAR Encephalitis
por: Sahar, Najmus
Publicado: (2018)

Isolated Memory Loss in Anti-NMDAR Encephalitis
por: Iorio, Raffaele, et al.
Publicado: (2021)

Serum-Derived Exosomal miR-140-5p as a Promising Biomarker for Differential Diagnosis of Anti-NMDAR Encephalitis With Viral Encephalitis
por: Liu, Xiaofeng, et al.
Publicado: (2022)

Case Report: Anti-LGI1 Limbic Encephalitis Associated With Anti-thyroid Autoantibodies
por: Otiniano-Sifuentes, Ricardo, et al.
Publicado: (2021)

CSF Findings in Acute NMDAR and LGI1 Antibody–Associated Autoimmune Encephalitis
por: Dürr, Marc, et al.
Publicado: (2021)

Clinical characteristics and long-term follow-up of seven cases of anti-GABABR encephalitis in patients of Han Chinese descent
por: Zeng, Wei, et al.
Publicado: (2019)

Anti-NMDAR encephalitis in Crohn’s disease undergoing long-term infliximab treatment: A case report
por: Oh, Shin Ju, et al.
Publicado: (2022)

Cytokine/chemokine levels in the CSF and serum of anti-NMDAR encephalitis: A systematic review and meta-analysis
por: Ma, Yushan, et al.
Publicado: (2023)

Case Report: Paroxysmal weakness of unilateral limb as an initial symptom in anti-LGI1 encephalitis: a report of five cases
por: Wang, Shan, et al.
Publicado: (2023)

Recognition of seizure semiology and semiquantitative FDG‐PET analysis of anti‐LGI1 encephalitis
por: Li, Tao‐Ran, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lgvktovjh6ivoamopcjn4hc4r6